Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 59–59 | Cite as

BCG vaccine

Lymphadenitis: 10 case reports
Case report
  • 30 Downloads
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

In a case series, ten infants (aged 1−6 months) were described [sexes not stated], who developed lymphadenitis following administration of BCG vaccine [dosages and time to reactions onsets not stated; not all outcomes stated].

Case 1: A 2.5-month-old infant was administered intradermal BCG vaccine for immunisation against tuberculosis. Subsequently, the infant developed lymphadenitis with involvement of the left supraclavicular lymph node. Swelling and ulceration of the lymph nodes were observed. The infant was referred to the paediatric surgery department. Later, the infant was lost to follow-up.

Case 2: A 3-month-old infant was administered intradermal BCG vaccine for immunisation against tuberculosis. Subsequently, the infant developed lymphadenitis with involvement of...

Reference

  1. Manju V, et al. Upsurge in BCG vaccine induced lymphadenitis: Case series. Journal of Young Pharmacists 10: 123-125, No. 1, Mar 2018. Available from: URL: http://doi.org/10.5530/jyp.2018.10.27 - IndiaCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations